UNSPSC 85705229: Supplement left tarsal with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left tarsal with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QUM37Z

UNSPSC 85705229 Supplement left tarsal with autologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity in state and local procurement. The recent opportunities tagged under this code do not align with its nominal scope of orthopedic surgical procedures. Instead, the postings cover independent medical evaluation services for disability pension determinations, occupational health surveillance for ferry employees, emergency and specialty care for detained youth, pharmacy benefit management administration, temporary health professional staffing, and surgical procedure carve-out benefits for government employees—none of which describe tarsal joint supplementation or autologous tissue grafting performed by state or local procurement offices themselves. The mismatch suggests that either the code assignment in the source records is incorrect or that state and local governments do not actively procure this specific surgical procedure as a standalone service line.

The issuing bodies in the available records span city retirement offices, state transportation departments, county health systems and juvenile justice authorities, and municipal benefits administrators across Arizona, Washington, Florida, California, and Texas. Without opportunities that actually solicit orthopedic surgical procedures matching the code's clinical description, this Commodity code does not present a viable business development target for vendors seeking state and local procurement activity in 2026.